| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Finance, &CAO | Chief Accounting Officer
1 company
Zakrowski Donald A is a SVP, Finance, &CAO at ELI LILLY & Co. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 1,000 | $1,010.50 | $1,010,500.00 | -26.0% | -0.7% | - | |
| Aug 28, 2025 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 1,000 | $734.93 | $734,930.00 | -20.7% | +50.9% | - | |
| May 27, 2025 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 1,000 | $716.41 | $716,410.00 | -17.1% | -4.1% | +49.3% | |
| Mar 13, 2025 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 1,000 | $818.24 | $818,240.00 | -14.6% | +0.9% | +22.9% | |
| Nov 8, 2024 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 900 | $803.38 | $723,042.00 | -14.1% | +4.7% | +11.2% | |
| Aug 26, 2024 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 750 | $950.00 | $712,500.00 | -10.5% | -20.6% | -22.6% | |
| Jun 3, 2024 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 750 | $819.47 | $614,602.50 | -9.5% | +15.1% | -9.7% | |
| Mar 11, 2024 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 750 | $753.60 | $565,200.00 | -8.7% | +17.8% | +12.2% | |
| Nov 6, 2023 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 670 | $571.10 | $382,637.00 | -12.5% | +18.7% | +35.4% | |
| Aug 21, 2023 | LLY Eli Lilly & Co | SVP, Finance, &CAO | Sell | 600 | $546.51 | $327,906.00 | -10.0% | +8.6% | +72.7% |